Scynexis (SCYX) Cash & Equivalents (QoQ) (2013 - 2026)
Scynexis (SCYX) Cash & Equivalents (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Scynexis | 62.02 Mn | -52.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.80% |
| Mar 31, 2026 | 72.50% |
| Dec 31, 2025 | -43.91% |
| Sep 30, 2025 | 243.92% |
| Jun 30, 2025 | -79.52% |
| Mar 31, 2025 | 235.18% |
| Dec 31, 2024 | -44.13% |
| Sep 30, 2024 | -65.68% |
| Jun 30, 2024 | 135.89% |
| Mar 31, 2024 | 4.21% |
| Dec 31, 2023 | -67.63% |
| Sep 30, 2023 | 81.68% |
| Jun 30, 2023 | 115.16% |
| Mar 31, 2023 | -41.26% |
| Dec 31, 2022 | -33.24% |
| Sep 30, 2022 | -42.19% |
| Jun 30, 2022 | 24.67% |
| Mar 31, 2022 | -8.88% |
| Dec 31, 2021 | 4.37% |
| Sep 30, 2021 | -10.94% |